Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Capricor Therapeutics (CAPR) Shares Outstanding (Diluted Average) (2016 - 2025)

Capricor Therapeutics has reported Shares Outstanding (Diluted Average) over the past 9 years, most recently at $46.5 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $46.5 million for Q4 2025, up 31.97% from a year ago — trailing twelve months through Dec 2025 was $46.5 million (up 31.97% YoY), and the annual figure for FY2025 was $46.5 million, up 31.97%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $46.5 million at Capricor Therapeutics, up from $45.7 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for CAPR hit a ceiling of $46.5 million in Q4 2025 and a floor of $22.2 million in Q1 2021.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $25.4 million (2023), compared with a mean of $30.3 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): surged 107.74% in 2021 and later increased 3.97% in 2023.
  • Capricor Therapeutics' Shares Outstanding (Diluted Average) stood at $23.1 million in 2021, then rose by 6.34% to $24.6 million in 2022, then increased by 9.06% to $26.8 million in 2023, then surged by 31.52% to $35.2 million in 2024, then soared by 31.97% to $46.5 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $46.5 million (Q4 2025), $45.7 million (Q3 2025), and $45.7 million (Q2 2025) per Business Quant data.